Annual D&A:
$2.78M+$675.00K(+32.13%)Summary
- As of today, RNA annual D&A is $2.78 million, with the most recent change of +$675.00 thousand (+32.13%) on December 31, 2024.
- During the last 3 years, RNA annual D&A has risen by +$2.14 million (+334.43%).
- RNA annual D&A is now at all-time high.
Performance
RNA Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$1.06M+$242.00K(+29.73%)Summary
- As of today, RNA quarterly D&A is $1.06 million, with the most recent change of +$242.00 thousand (+29.73%) on September 30, 2025.
- Over the past year, RNA quarterly D&A has increased by +$346.00 thousand (+48.73%).
- RNA quarterly D&A is now -18.77% below its all-time high of $1.30 million, reached on September 30, 2023.
Performance
RNA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$3.39M+$346.00K(+11.36%)Summary
- As of today, RNA TTM D&A is $3.39 million, with the most recent change of +$346.00 thousand (+11.36%) on September 30, 2025.
- Over the past year, RNA TTM D&A has increased by +$2.89 million (+579.96%).
- RNA TTM D&A is now -15.62% below its all-time high of $4.02 million, reached on September 30, 2023.
Performance
RNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RNA Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +32.1% | +48.7% | +580.0% |
| 3Y3 Years | +334.4% | +185.4% | +179.5% |
| 5Y5 Years | +697.7% | +945.5% | +1215.1% |
RNA Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +334.4% | -18.8% | +168.6% | -15.6% | +580.0% |
| 5Y | 5-Year | at high | +697.7% | -18.8% | +168.6% | -15.6% | +1215.1% |
| All-Time | All-Time | at high | +697.7% | -18.8% | +168.6% | -15.6% | +2103.3% |
RNA Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.06M(+29.7%) | $3.39M(+11.4%) |
| Jun 2025 | - | $814.00K(+3.7%) | $3.05M(+4.3%) |
| Mar 2025 | - | $785.00K(+6.4%) | $2.92M(+5.2%) |
| Dec 2024 | $2.78M(+32.1%) | $738.00K(+3.9%) | $2.78M(+456.3%) |
| Sep 2024 | - | $710.00K(+3.3%) | $499.00K(-54.2%) |
| Jun 2024 | - | $687.00K(+7.2%) | $1.09M(-34.5%) |
| Mar 2024 | - | $641.00K(+141.7%) | $1.66M(-20.8%) |
| Dec 2023 | $2.10M(+51.5%) | -$1.54M(-218.4%) | $2.10M(-47.7%) |
| Sep 2023 | - | $1.30M(+3.1%) | $4.02M(+30.1%) |
| Jun 2023 | - | $1.26M(+16.9%) | $3.09M(+43.6%) |
| Mar 2023 | - | $1.08M(+183.2%) | $2.15M(+55.2%) |
| Dec 2022 | $1.39M | $381.00K(+3.0%) | $1.39M(+14.3%) |
| Sep 2022 | - | $370.00K(+14.9%) | $1.21M(+19.0%) |
| Jun 2022 | - | $322.00K(+2.5%) | $1.02M(+20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $314.00K(+51.0%) | $845.00K(+32.2%) |
| Dec 2021 | $639.00K(+71.3%) | $208.00K(+18.2%) | $639.00K(+17.0%) |
| Sep 2021 | - | $176.00K(+19.7%) | $546.00K(+15.9%) |
| Jun 2021 | - | $147.00K(+36.1%) | $471.00K(+38.1%) |
| Mar 2021 | - | $108.00K(-6.1%) | $341.00K(-8.6%) |
| Dec 2020 | $373.00K(+7.2%) | $115.00K(+13.9%) | $373.00K(+44.6%) |
| Sep 2020 | - | $101.00K(+494.1%) | $258.00K(+7.1%) |
| Jun 2020 | - | $17.00K(-87.9%) | $241.00K(-4.0%) |
| Mar 2020 | - | $140.00K(+66.7%) | $251.00K(-5.3%) |
| Dec 2019 | $348.00K(-9.1%) | - | - |
| Sep 2019 | - | $84.00K(+211.1%) | $265.00K(+46.4%) |
| Jun 2019 | - | $27.00K(-82.5%) | $181.00K(+17.5%) |
| Mar 2019 | - | $154.00K | $154.00K |
| Dec 2018 | $383.00K | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual D&A?
- What is the all-time high annual D&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual D&A year-on-year change?
- What is Avidity Biosciences, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly D&A year-on-year change?
- What is Avidity Biosciences, Inc. TTM D&A?
- What is the all-time high TTM D&A for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM D&A year-on-year change?
What is Avidity Biosciences, Inc. annual D&A?
The current annual D&A of RNA is $2.78M
What is the all-time high annual D&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual D&A is $2.78M
What is Avidity Biosciences, Inc. annual D&A year-on-year change?
Over the past year, RNA annual D&A has changed by +$675.00K (+32.13%)
What is Avidity Biosciences, Inc. quarterly D&A?
The current quarterly D&A of RNA is $1.06M
What is the all-time high quarterly D&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly D&A is $1.30M
What is Avidity Biosciences, Inc. quarterly D&A year-on-year change?
Over the past year, RNA quarterly D&A has changed by +$346.00K (+48.73%)
What is Avidity Biosciences, Inc. TTM D&A?
The current TTM D&A of RNA is $3.39M
What is the all-time high TTM D&A for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM D&A is $4.02M
What is Avidity Biosciences, Inc. TTM D&A year-on-year change?
Over the past year, RNA TTM D&A has changed by +$2.89M (+579.96%)